Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

March 15, 2010 (Vol. 30, No. 6)

New Predictive ADME/Tox Strategies Reduce Attrition

Emerging Methods Now Assess Absorption, Transport, and Bioavailability Sooner

  • Predictive toxicology tools and safety strategies put in place earlier in the drug-development process will begin to deliver in the future, according to Stephane Dhalluin, Ph.D., director of investigative nonclinical safety at UCB Pharma, who spoke at Mondial Research Group’s “Predictive Human Toxicity and ADME/Tox Studies” conference held recently in ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.